| Medius AG - FLUAD, Injektionssuspension | | 58317 | | 10 | | FLUAD | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 03.09.2016 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181), haemagglutininum influenzae A (H3N2) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/Hong Kong/4801/2014 (H3N2)-like: reassortant virus NYMC X-263B), haemagglutininum influenzae B 15 µg et neuraminidasum inactivatum (Virus-Stamm B/Brisbane/60/2008), adjuvans MF59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension injectable | | | | | | Principe actif | Concentr. |
|---|
| Haemagglutininum Influenzae a (H1N1) | 15 µg | | Haemagglutininum Influenzae a (H3N2) | 15 µg | | Neuraminidasum Inactivatum (Virus-Stamm A/california/7/2009 (H1N1)-Like: Reassortant Virus nymc X-181) | |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Acide Citrique | | | | Calcium Chlorure | | | | Disodium Phosphate Dihydrate | | | | Haemagglutininum Influenzae b 15 µg et Neuraminidasum Inactivatum (Virus-Stamm B/brisbane/60/2008) | | | | Potassium Chlorure | | | | Potassium Dihydrogenophosphate | | | | Magnesium Chloride Hexahydrate | | | | Sodium Chlorure | | excipiens | | Natrii Citras Dihydricus | | | | Neuraminidasum Inactivatum (Virus-Stamm A/hong Kong/4801/2014 (H3N2)-Like: Reassortant Virus nymc X-263b) | | | | Polysorbatum 80 | | | | Sorbitani Trioleas | | | | Squalenum | | adjuvans MF59 |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
